Literature DB >> 35707177

Expert Discussion: Hypofractionated Radiation Therapy - Standard for All Indications?

Gerd Fastner1, David Krug2, Icro Meattini3,4, Günther Gruber5,6, Philip Poortmans7,8.   

Abstract

Entities:  

Year:  2021        PMID： 35707177      PMCID： PMC9149542          DOI： 10.1159/000521552

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.268


× No keyword cloud information.
  45 in total

1.  Meta-analysis of long-term efficacy and safety of hypofractionated radiotherapy in the treatment of early breast cancer.

Authors:  Teresa R M Andrade; Marcelo C M Fonseca; Helena R C Segreto; Roberto A Segreto; Eduardo Martella; Afonso C P Nazário
Journal:  Breast       Date:  2019-08-16       Impact factor: 4.380

2.  Long-term results of hypofractionated radiation therapy for breast cancer.

Authors:  Timothy J Whelan; Jean-Philippe Pignol; Mark N Levine; Jim A Julian; Robert MacKenzie; Sameer Parpia; Wendy Shelley; Laval Grimard; Julie Bowen; Himu Lukka; Francisco Perera; Anthony Fyles; Ken Schneider; Sunil Gulavita; Carolyn Freeman
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

3.  Brachial plexopathy after postoperative radiotherapy of breast cancer patients--a long-term follow-up.

Authors:  S Johansson; H Svensson; L G Larsson; J Denekamp
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

4.  Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines.

Authors:  Anke M van Mourik; Paula H M Elkhuizen; Danny Minkema; Joop C Duppen; Corine van Vliet-Vroegindeweij
Journal:  Radiother Oncol       Date:  2010-03-02       Impact factor: 6.280

5.  Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial.

Authors:  J M Immink; H Putter; H Bartelink; J S Cardoso; M J Cardoso; M H V van der Hulst-Vijgen; E M Noordijk; P M Poortmans; C C Rodenhuis; H Struikmans
Journal:  Ann Oncol       Date:  2012-04-12       Impact factor: 32.976

Review 6.  European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer.

Authors:  Icro Meattini; Carlotta Becherini; Liesbeth Boersma; Orit Kaidar-Person; Gustavo Nader Marta; Angel Montero; Birgitte Vrou Offersen; Marianne C Aznar; Claus Belka; Adrian Murray Brunt; Samantha Dicuonzo; Pierfrancesco Franco; Mechthild Krause; Mairead MacKenzie; Tanja Marinko; Livia Marrazzo; Ivica Ratosa; Astrid Scholten; Elżbieta Senkus; Hilary Stobart; Philip Poortmans; Charlotte E Coles
Journal:  Lancet Oncol       Date:  2022-01       Impact factor: 41.316

Review 7.  AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021.

Authors:  Nina Ditsch; Cornelia Kolberg-Liedtke; Michael Friedrich; Christian Jackisch; Ute-Susann Albert; Maggie Banys-Paluchowski; Ingo Bauerfeind; Jens-Uwe Blohmer; Wilfried Budach; Peter Dall; Eva M Fallenberg; Peter A Fasching; Tanja Fehm; Bernd Gerber; Oleg Gluz; Nadia Harbeck; Jörg Heil; Jens Huober; Hans-Heinrich Kreipe; David Krug; Thorsten Kühn; Sherko Kümmel; Sibylle Loibl; Diana Lüftner; Michael P Lux; Nicolai Maass; Christoph Mundhenke; Ulrike Nitz; Tjoung-Won Park-Simon; Toralf Reimer; Kerstin Rhiem; Achim Rody; Marcus Schmidt; Andreas Schneeweiss; Florian Schütz; Hans-Peter Sinn; Christine Solbach; Erich-Franz Solomayer; Elmar Stickeler; Christoph Thomssen; Michael Untch; Isabell Witzel; Achim Wöckel; Volkmar Müller; Wolfgang Janni; Marc Thill
Journal:  Breast Care (Basel)       Date:  2021-06-01       Impact factor: 2.268

8.  Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic.

Authors:  M Machiels; R Weytjens; W Bauwens; W Vingerhoed; C Billiet; P Huget; D Verellen; P Dirix; P Meijnders; P Poortmans; O Kaidar-Person
Journal:  Clin Oncol (R Coll Radiol)       Date:  2020-12-02       Impact factor: 4.126

9.  Why is appropriate healthcare inaccessible for many European breast cancer patients? - The EBCC 12 manifesto.

Authors:  Fatima Cardoso; Fiona MacNeill; Frederique Penault-Llorca; Alexandru Eniu; Francesco Sardanelli; Elizabeth Bergsten Nordström; Philip Poortmans
Journal:  Breast       Date:  2021-01-02       Impact factor: 4.380

10.  Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials.

Authors:  Joanne S Haviland; Mariella Mannino; Clare Griffin; Nuria Porta; Mark Sydenham; Judith M Bliss; John R Yarnold
Journal:  Radiother Oncol       Date:  2017-11-15       Impact factor: 6.280
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.